feed,title,long_url,short_url
SeekingAlpha,Safety board recommends Synthetic Biologics proceed in cell transplant recipients trial,https://seekingalpha.com/news/3886372,
SeekingAlpha,SPAC KINS Technology to buy Inpixion's enterprise apps business,https://seekingalpha.com/news/3886371,
SeekingAlpha,RH Faces A Litmus Test But I Remain Long,https://seekingalpha.com/article/4543328,
